Eisai reports dose comparison data from Lenvima thyroid cancer trial
The study enrolled 152 patients with RAI-refractory DTC. Credit: Vachagan Malkhasyan from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
